Related Articles
Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture
1α,25‑Dihydroxyvitamin D3 restrains stem cell‑like properties of ovarian cancer cells by enhancing vitamin D receptor and suppressing CD44
Differentiation of human breast carcinoma cells by a novel vitamin D analog: 1alpha-hydroxyvitamin D5.
Synergy of 1,25‑dihydroxyvitamin D3 and carboplatin in growth suppression of SKOV‑3 cells
Studies on the mechanisms of superagonistic pro-differentiating activities of side-chain modified analogs of vitamin D2